CA Stock MarketDetailed Quotes

Voyageur Pharmaceuticals Ltd (VM)

Watchlist
  • 0.165
  • +0.005+3.13%
15min DelayMarket Closed Jan 22 16:00 ET
29.44MMarket Cap-8.25P/E (TTM)

Voyageur Pharmaceuticals Ltd (VM) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Aug 31, 2025
(Q2)May 31, 2025
(Q1)Feb 28, 2025
(FY)Nov 30, 2024
(Q4)Nov 30, 2024
(Q3)Aug 31, 2024
(Q2)May 31, 2024
(Q1)Feb 29, 2024
(FY)Nov 30, 2023
(Q4)Nov 30, 2023
Total revenue
11.04K
0
0
0
0
0
0
0
0
0
Operating revenue
--11.04K
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
13.87K
0
Gross profit
-2.83K
0
Operating expense
262.53%1.3M
-3.14%544.26K
148.54%817.56K
26.21%1.7M
96.55%450.57K
174.80%359.13K
-9.59%561.9K
-11.97%328.95K
-23.15%1.35M
-59.98%229.24K
Selling and administrative expenses
113.34%532.05K
-20.85%320.21K
125.62%629.61K
30.41%1.23M
27.07%294.11K
245.75%249.39K
-1.53%404.54K
19.09%279.06K
-12.52%940.01K
-38.17%231.46K
-General and administrative expense
113.34%532.05K
-20.85%320.21K
125.62%629.61K
30.41%1.23M
27.07%294.11K
245.75%249.39K
-1.53%404.54K
19.09%279.06K
-12.52%940.01K
-38.17%231.46K
Research and development costs
719.36%527.38K
-48.06%54.44K
220.29%40.47K
2.31%287.44K
1,227.43%105.62K
73.64%64.37K
-36.83%104.82K
-85.53%12.63K
-46.75%280.94K
-109.74%-9.37K
Depreciation amortization depletion
-27.99%283
-27.99%283
-27.99%283
-28.15%1.57K
-28.21%392
-28.02%393
-28.02%393
-28.02%393
-24.86%2.19K
-24.90%546
-Depreciation and amortization
-27.99%283
-27.99%283
-27.99%283
-28.15%1.57K
-28.21%392
-28.02%393
-28.02%393
-28.02%393
-24.86%2.19K
-24.90%546
Other operating expenses
438.55%242.25K
224.68%169.32K
299.30%147.2K
49.66%184.44K
664.00%50.45K
114.77%44.98K
18.10%52.15K
-28.47%36.87K
-16.11%123.24K
-93.50%6.6K
Operating profit
-263.32%-1.3M
3.14%-544.26K
-148.54%-817.56K
-26.21%-1.7M
-96.55%-450.57K
-174.80%-359.13K
9.59%-561.9K
11.97%-328.95K
23.15%-1.35M
59.98%-229.24K
Net non-operating interest income (expenses)
0
-4.48K
Non-operating interest expense
----
----
----
--0
----
----
----
----
--4.48K
----
Other net income (expenses)
83.66%-7.94K
-2,368.77%-48.61K
Special income (charges)
----
----
----
83.66%-7.94K
----
----
----
--0
-2,368.77%-48.61K
----
-Less:Impairment of capital assets
----
----
----
-83.66%7.94K
----
----
----
--0
--48.61K
----
Income before tax
-263.32%-1.3M
3.14%-544.26K
-148.54%-817.56K
-21.99%-1.71M
-62.40%-458.51K
-174.80%-359.13K
9.59%-561.9K
11.97%-328.95K
20.21%-1.4M
50.88%-282.33K
Income tax
Earnings from equity interest net of tax
Net income
-263.32%-1.3M
3.14%-544.26K
-148.54%-817.56K
-21.99%-1.71M
-62.40%-458.51K
-174.80%-359.13K
9.59%-561.9K
11.97%-328.95K
20.21%-1.4M
50.88%-282.33K
Net income continuous operations
-263.32%-1.3M
3.14%-544.26K
-148.54%-817.56K
-21.99%-1.71M
-62.40%-458.51K
-174.80%-359.13K
9.59%-561.9K
11.97%-328.95K
20.21%-1.4M
50.88%-282.33K
Noncontrolling interests
Net income attributable to the company
-263.32%-1.3M
3.14%-544.26K
-148.54%-817.56K
-21.99%-1.71M
-62.40%-458.51K
-174.80%-359.13K
9.59%-561.9K
11.97%-328.95K
20.21%-1.4M
50.88%-282.33K
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
-263.32%-1.3M
3.14%-544.26K
-148.54%-817.56K
-21.99%-1.71M
-62.40%-458.51K
-174.80%-359.13K
9.59%-561.9K
11.97%-328.95K
20.21%-1.4M
50.88%-282.33K
Diluted earnings per share
-0.01
0
-0.01
0.00%-0.01
0
0
0
0
50.00%-0.01
0
Basic earnings per share
-0.01
0
-0.01
0.00%-0.01
0
0
0
0
50.00%-0.01
0
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Aug 31, 2025(Q2)May 31, 2025(Q1)Feb 28, 2025(FY)Nov 30, 2024(Q4)Nov 30, 2024(Q3)Aug 31, 2024(Q2)May 31, 2024(Q1)Feb 29, 2024(FY)Nov 30, 2023(Q4)Nov 30, 2023
Total revenue 11.04K000000000
Operating revenue --11.04K--0--0--0--0--0--0--0--0--0
Cost of revenue 13.87K0
Gross profit -2.83K0
Operating expense 262.53%1.3M-3.14%544.26K148.54%817.56K26.21%1.7M96.55%450.57K174.80%359.13K-9.59%561.9K-11.97%328.95K-23.15%1.35M-59.98%229.24K
Selling and administrative expenses 113.34%532.05K-20.85%320.21K125.62%629.61K30.41%1.23M27.07%294.11K245.75%249.39K-1.53%404.54K19.09%279.06K-12.52%940.01K-38.17%231.46K
-General and administrative expense 113.34%532.05K-20.85%320.21K125.62%629.61K30.41%1.23M27.07%294.11K245.75%249.39K-1.53%404.54K19.09%279.06K-12.52%940.01K-38.17%231.46K
Research and development costs 719.36%527.38K-48.06%54.44K220.29%40.47K2.31%287.44K1,227.43%105.62K73.64%64.37K-36.83%104.82K-85.53%12.63K-46.75%280.94K-109.74%-9.37K
Depreciation amortization depletion -27.99%283-27.99%283-27.99%283-28.15%1.57K-28.21%392-28.02%393-28.02%393-28.02%393-24.86%2.19K-24.90%546
-Depreciation and amortization -27.99%283-27.99%283-27.99%283-28.15%1.57K-28.21%392-28.02%393-28.02%393-28.02%393-24.86%2.19K-24.90%546
Other operating expenses 438.55%242.25K224.68%169.32K299.30%147.2K49.66%184.44K664.00%50.45K114.77%44.98K18.10%52.15K-28.47%36.87K-16.11%123.24K-93.50%6.6K
Operating profit -263.32%-1.3M3.14%-544.26K-148.54%-817.56K-26.21%-1.7M-96.55%-450.57K-174.80%-359.13K9.59%-561.9K11.97%-328.95K23.15%-1.35M59.98%-229.24K
Net non-operating interest income (expenses) 0-4.48K
Non-operating interest expense --------------0------------------4.48K----
Other net income (expenses) 83.66%-7.94K-2,368.77%-48.61K
Special income (charges) ------------83.66%-7.94K--------------0-2,368.77%-48.61K----
-Less:Impairment of capital assets -------------83.66%7.94K--------------0--48.61K----
Income before tax -263.32%-1.3M3.14%-544.26K-148.54%-817.56K-21.99%-1.71M-62.40%-458.51K-174.80%-359.13K9.59%-561.9K11.97%-328.95K20.21%-1.4M50.88%-282.33K
Income tax
Earnings from equity interest net of tax
Net income -263.32%-1.3M3.14%-544.26K-148.54%-817.56K-21.99%-1.71M-62.40%-458.51K-174.80%-359.13K9.59%-561.9K11.97%-328.95K20.21%-1.4M50.88%-282.33K
Net income continuous operations -263.32%-1.3M3.14%-544.26K-148.54%-817.56K-21.99%-1.71M-62.40%-458.51K-174.80%-359.13K9.59%-561.9K11.97%-328.95K20.21%-1.4M50.88%-282.33K
Noncontrolling interests
Net income attributable to the company -263.32%-1.3M3.14%-544.26K-148.54%-817.56K-21.99%-1.71M-62.40%-458.51K-174.80%-359.13K9.59%-561.9K11.97%-328.95K20.21%-1.4M50.88%-282.33K
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders -263.32%-1.3M3.14%-544.26K-148.54%-817.56K-21.99%-1.71M-62.40%-458.51K-174.80%-359.13K9.59%-561.9K11.97%-328.95K20.21%-1.4M50.88%-282.33K
Diluted earnings per share -0.010-0.010.00%-0.01000050.00%-0.010
Basic earnings per share -0.010-0.010.00%-0.01000050.00%-0.010
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
HK Tech and Internet Stocks
View More
Nancy Pelosi Portfolio
Tariff game between the US and Europe shakes the market! Will TACO happen again?
Amidst the global market turbulence triggered by the US-Europe dispute over Greenland, a single post by Trump instantly reversed market tren Show More